Top-selling drug
AstraZeneca’s Tagrisso dominates lung cancer market with projected $7B sales by 2025
Anika Sharma
The lung cancer drug market has been notably dominated by antibodies and immunotherapies, but a recent report from GlobalData suggests ...
